Unknown

Dataset Information

Partial-Methylated HeyL Promoter Predicts the Severe Illness in Egyptian COVID-19 Patients.


ABSTRACT:

Background

To date (14 January 2022), the incidence and related mortality rate of COVID-19 in America, Europe, and Asia despite administrated of billions doses of many approved vaccines are still higher than in Egypt. Epigenetic alterations mediate the effects of environmental factors on the regulation of genetic material causing many diseases.

Objective

We aimed to explore the methylation status of HeyL promoter, a downstream transcription factor in Notch signal, an important regulator of cell proliferation and differentiation blood, pulmonary epithelial, and nerves cells.

Methods

Our objective was achieved by DNA sequencing of the product from methyl-specific PCR of HeyL promoter after bisulfite modification of DNA extracted from the blood samples of 30 COVID-19 pat

SUBMITTER: Fadel HH 

PROVIDER: S-EPMC9153385 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature